SLC2A4 and Insulin resistance: Thus, this inhibits Akt’s transport to the plasma membrane, disrupts the Akt/PKB pathway, reduced GLUT 4 expression levels, and perturbs the glucose transporter pathway, leading to insulin resistance (Mandal et al., 2021).